RUNX1 and type 2 diabetes mellitus: Transcriptomes of macrophages in atherosclerotic plaques and peripheral leukocytes from patients with type 2 diabetes were enriched in RUNX1 targets, and targeting RUNX1 provided further evidence for the involvement of RUNX1 in the downstream effects of hyperglycemia-induced trained immunity in macrophages 36.